Solventum Corp Files 8-K on Officer/Director Changes

TL;DR

Solventum Corp (formerly 3M Health Care) filed an 8-K detailing executive and director changes.

AI Summary

Solventum Corporation, formerly 3M Health Care Co, filed an 8-K on April 16, 2024, reporting events as of April 12, 2024. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Solventum Corporation is incorporated in Delaware and its principal executive offices are located at 3M Center, Maplewood, MN.

Why It Matters

This filing indicates significant corporate governance and executive changes at Solventum Corporation, which could impact its strategic direction and operational management.

Risk Assessment

Risk Level: medium — Changes in key officers and directors can signal shifts in strategy or internal dynamics, requiring investor attention.

Key Numbers

• 001-41968 — SEC File Number (Identifier for Solventum Corp's SEC filings)
• 92-2008841 — IRS Employer Identification No. (Tax identification for Solventum Corp)

Key Players & Entities

• Solventum Corporation (company) — Registrant
• 3M Health Care Co (company) — Former Name
• 3M Company (company) — Related Company
• April 12, 2024 (date) — Date of earliest event reported
• April 16, 2024 (date) — Date of Report
• Delaware (location) — State of Incorporation
• Maplewood, MN (location) — Principal Executive Offices

FAQ

From the Filing

0001964738-24-000010.txt : 20240416 0001964738-24-000010.hdr.sgml : 20240416 20240416163551 ACCESSION NUMBER: 0001964738-24-000010 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240412 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240416 DATE AS OF CHANGE: 20240416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 24848259 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 solv-20240412.htm 8-K solv-20240412 FALSE 0001964738 0001964738 2024-04-12 2024-04-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 12, 2024 Solventum Corporation (Exact name of registrant as specified in its charter) Delaware 001-41968 92-2008841 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East Maplewood , MN 55144 (Address of Principal Executive Offices, including Zip code) ( 651 ) 733-1110 (Registrant’s telephone number, including area code) (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share SOLV New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On April 12, 2024, the Board of Directors (the “Board”) of Solventum Corporation (the “Company”) elected Shirley A. Edwards to the Company’s Board, effective April 12, 2024. Ms. Edwards was a Partner at EY (formerly Ernst & Young LLP) from 2002 to 2022, most recently serving as a Global Client Service Partner from 2017 to 2022. Ms. Edwards will join the Board as a Class II director, and her term will expire with the terms of the other Class II directors at the 20